X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs PANACEA BIOTECH - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH PANACEA BIOTECH STERLING BIOTECH/
PANACEA BIOTECH
 
P/E (TTM) x -1.6 170.2 - View Chart
P/BV x 0.1 3.8 1.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   PANACEA BIOTECH
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
PANACEA BIOTECH
Mar-14
STERLING BIOTECH/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs11149 7.1%   
Low Rs382 4.1%   
Sales per share (Unadj.) Rs26.884.1 31.9%  
Earnings per share (Unadj.) Rs-15.0-18.3 81.7%  
Cash flow per share (Unadj.) Rs-5.5-6.7 81.5%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.983.7 65.6%  
Shares outstanding (eoy) m267.8761.25 437.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.4 18.9%   
Avg P/E ratio x-0.5-6.3 7.4%  
P/CF ratio (eoy) x-1.3-17.2 7.4%  
Price / Book Value ratio x0.11.4 9.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8627,074 26.3%   
No. of employees `0001.42.8 49.2%   
Total wages/salary Rs m5471,449 37.7%   
Avg. sales/employee Rs Th5,303.31,874.1 283.0%   
Avg. wages/employee Rs Th403.8527.0 76.6%   
Avg. net profit/employee Rs Th-2,959.0-407.7 725.7%   
INCOME DATA
Net Sales Rs m7,1815,154 139.3%  
Other income Rs m43100 42.7%   
Total revenues Rs m7,2235,254 137.5%   
Gross profit Rs m947-766 -123.6%  
Depreciation Rs m2,543711 357.7%   
Interest Rs m4,3771,503 291.2%   
Profit before tax Rs m-5,931-2,881 205.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m-1,92417 -11,454.2%   
Profit after tax Rs m-4,007-1,121 357.3%  
Gross profit margin %13.2-14.9 -88.7%  
Effective tax rate %32.4-0.6 -5,563.1%   
Net profit margin %-55.8-21.8 256.4%  
BALANCE SHEET DATA
Current assets Rs m14,3353,810 376.2%   
Current liabilities Rs m49,8098,365 595.4%   
Net working cap to sales %-494.0-88.4 558.9%  
Current ratio x0.30.5 63.2%  
Inventory Days Days403156 259.1%  
Debtors Days Days17167 253.8%  
Net fixed assets Rs m55,43214,480 382.8%   
Share capital Rs m26861 437.0%   
"Free" reserves Rs m13,935903 1,543.0%   
Net worth Rs m14,7015,127 286.7%   
Long term debt Rs m9,4785,832 162.5%   
Total assets Rs m73,98819,433 380.7%  
Interest coverage x-0.4-0.9 38.7%   
Debt to equity ratio x0.61.1 56.7%  
Sales to assets ratio x0.10.3 36.6%   
Return on assets %0.52.0 25.5%  
Return on equity %-27.3-21.9 124.6%  
Return on capital %-6.43.6 -176.7%  
Exports to sales %25.924.5 105.6%   
Imports to sales %0.210.2 1.7%   
Exports (fob) Rs m1,8601,264 147.2%   
Imports (cif) Rs m12525 2.3%   
Fx inflow Rs m1,8601,539 120.8%   
Fx outflow Rs m25942 2.6%   
Net fx Rs m1,835597 307.3%   
CASH FLOW
From Operations Rs m1,719599 286.8%  
From Investments Rs m-3,148-438 718.9%  
From Financial Activity Rs m1,426-303 -471.2%  
Net Cashflow Rs m-3-141 2.4%  

Share Holding

Indian Promoters % 33.9 74.5 45.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 9.9 1.3 761.5%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 23.6 166.5%  
Shareholders   21,482 10,259 209.4%  
Pledged promoter(s) holding % 55.9 35.1 159.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Down Around 1%; Telecom & Metal Stocks Decline(01:30 pm)

Indian share markets are trading in the red presently. Sectoral indices are trading in the red with stocks in the telecom sector and metal sector witnessing maximum selling pressure.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 19, 2018 01:59 PM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS